Former general counsel of Novo Nordisk joins Lowenstein Sandler

By 2016-07-22T10:15:00

Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.